GrowingStockReport.com

Cytori Therapeutics, Inc. (NASDAQ:CYTX) and Oncothyreon Inc (NASDAQ:ONTY) Added to Growing Stock Report's NASDAQ Gainers Watch List.

 

New York, NY -- (ReleaseWire) -- 04/23/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Cytori Therapeutics, Inc. (NASDAQ:CYTX) and Oncothyreon Inc (NASDAQ:ONTY).

Cytori Therapeutics, Inc. (NASDAQ:CYTX) a cell therapy company that engages in developing cell therapies based on autologous adipose-derived regenerative cells to treat cardiovascular diseases, burns, and other soft tissue injuries closed up in its previous session (+8.87%) on 415,276 shares traded. Cytori Therapeutics, Inc. (NASDAQ:CYTX) is currently up (+38.81%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Cytori Therapeutics, Inc. (NASDAQ:CYTX)

Oncothyreon Inc (NASDAQ:ONTY) a clinical-stage biopharmaceutical company that engages in the development of therapeutic products for the treatment of cancer closed up in its previous session (+8.92%) on 2,008,856 shares traded. Oncothyreon Inc (NASDAQ:ONTY) is currently up (+59.06%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Oncothyreon Inc (NASDAQ:ONTY)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com